---
title: 'Precision Medicine for High-Risk Gene Fusions in Pediatric AML: a focus on
  KMT2A, NUP98, and GLIS2 Rearrangements'
date: '2025-01-14'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39808803/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20250115170812&v=2.18.0.post9+e462414
source: Blood
description: Robust genetic characterization of paediatric AML has demonstrated that
  fusion oncogenes are highly prevalent drivers of AML leukemogenesis in young children.
  Identification of fusion oncogenes associated with adverse outcomes has facilitated
  risk stratification of patients, although successful development of precision medicine
  approaches for most fusion-driven AML subtypes have been historically challenging.
  This knowledge gap has been in part due to difficulties in targeting ...
disable_comments: true
---
Robust genetic characterization of paediatric AML has demonstrated that fusion oncogenes are highly prevalent drivers of AML leukemogenesis in young children. Identification of fusion oncogenes associated with adverse outcomes has facilitated risk stratification of patients, although successful development of precision medicine approaches for most fusion-driven AML subtypes have been historically challenging. This knowledge gap has been in part due to difficulties in targeting ...